Current Medicinal Chemistry
Title:Editorial: Different Classes of Natural Products as Promising Scaffolds for the Development of Therapeutic Agents: New Drugs from “Old” Natural Products
Volume: 25 Issue: 10
Author(s): Dall'Acqua Stefano*
Affiliation:
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35121, Padova,Italy
Export Options
About this article
Cite this article as:
Stefano Dall'Acqua *, Editorial: Different Classes of Natural Products as Promising Scaffolds for the Development of Therapeutic Agents: New Drugs from “Old” Natural Products, Current Medicinal Chemistry 2018; 25 (10) . https://dx.doi.org/10.2174/092986732510180409145323
DOI https://dx.doi.org/10.2174/092986732510180409145323 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Approaches to Quantification of RNA Targets by PCR Based Techniques
Current Genomics Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
Current Medicinal Chemistry Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Identification and Preclinical Evaluation of SC144, a Novel Pyrroloquinoxaline Derivative with Broad-Spectrum Anticancer Activity
Mini-Reviews in Medicinal Chemistry Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Current Drug Targets Association between the Polymorphisms of TLR4 and CD14 Genes and Alzheimers Disease
Current Pharmaceutical Design Non-Small Cell Lung Cancer: From Cytotoxic Systemic Chemotherapy to Molecularly Targeted Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Oxidative Stress and Psychological Disorders
Current Neuropharmacology Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases
Current Pharmaceutical Design Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses
Current Pharmaceutical Biotechnology EDITORIAL: Repurposing Niacin as Antiplatelet Drug?
Current Clinical Pharmacology Antibody-Based Therapies in Systemic Lupus Erythematosus
Mini-Reviews in Medicinal Chemistry Human Amnion-Derived Cells: Prospects for the Treatment of Lung Diseases
Current Stem Cell Research & Therapy Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Detection of Fungal Infections Using Radiolabeled Antifungal Agents
Current Drug Targets Tryptophan Fluorescence Quenching by Enzyme Inhibitors As a Tool for Enzyme Active Site Structure Investigation: Epoxide Hydrolase
Current Pharmaceutical Biotechnology Hyaluronan Fragmentation During Inflammatory Pathologies: A Signal that Empowers Tissue Damage
Mini-Reviews in Medicinal Chemistry ACKNOWLEDGEMENTS TO CONTRIBUTORS
Recent Patents on Inflammation & Allergy Drug Discovery Platelet-Monocyte Interactions - A Dangerous Liaison Linking Thrombosis, Inflammation and Atherosclerosis
Current Medicinal Chemistry Macrophage Activation in Atherosclerosis: Pathogenesis and Pharmacology of Plaque Rupture
Current Vascular Pharmacology